Medication Recommendations

One of the key goals of BCPRA’s Pharmacy & Formulary Review Committee is to facilitate medication best practices. The implementation of best practices processes in the management of expensive medications could save an estimated five to ten percent of the current $29 million renal drug budget.

As well, by using medication in a fiscally responsible manner, we are able to expand the list of formulary offerings at little additional cost.

The Pharmacy & Formulary committee has prepared a summary of monthly costs for drugs features on the BCPRA formulary.

Medication choices will always remain at the discretion of individual physicians, in consultation with their patients. Implementation of BCPRA recommendations will be managed on a unit-by-unit basis. 

For more information, contact the BCPRA at 604-875-7340 or by email.

Iron Gluconate Recommendation, June 2006:
BCPRA recommends that where possible patients are switched from iron sucrose to iron gluconate. This change would result in yearly costs savings of up to $400,000 with no negative impact on patient safety or outcome.